Genenta Science is a startup based in Italy, most recent round Series-c-plus, 3 tracked investors.
Genenta Science is a company headquartered in Italy. Its most recent tracked round is Series-c-plus. Brouky records 3 investors associated with the company.
Genenta Science is a clinical-stage biotechnology company developing a gene transfer platform based on hematopoietic stem cells. Their technology aims to treat cancer by delivering therapeutic proteins directly to tumors.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.